![Joseph Oliveto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Oliveto
Chief Executive Officer at
MILESTONE PHARMACEUTICALS INC.
Net worth: 633 666 $ as of 2026-05-30
Profile
Mr. Joseph G.
Oliveto is a President & Chief Executive Officer at Milestone Pharmaceuticals USA, Inc. and a President, Chief Executive Officer & Director at Milestone Pharmaceuticals, Inc. He is on the Board of Directors at Milestone Pharmaceuticals, Inc. Mr. Oliveto was previously employed as a Chief Executive Officer & Director by Galleon Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Chelsea Therapeutics International Ltd., an Executive-in-Residence by A. M.
Pappas & Associates LLC, and a Director-Global Alliance by Hoffmann-La Roche, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-15 | 446,244 ( 0.36% ) | 633 666 $ | 2026-05-30 |
Joseph Oliveto active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Executive Officer | 2017-03-06 |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular drugs | Chief Executive Officer | 2017-03-06 |
Former positions of Joseph Oliveto
| Companies | Position | End |
|---|---|---|
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Chief Executive Officer | 2016-05-31 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Chief Executive Officer | 2014-06-22 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Corporate Officer/Principal | 2008-06-29 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | 2007-12-31 |
Training of Joseph Oliveto
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for breathing-control conditions | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular drugs | Health Technology |
- Stock Market
- Insiders
- Joseph Oliveto
